Rizatriptan Benzoate
- Product NDC
- 72189-512
- 11-digit product format
- 721890512
- Labeler code
- 72189
- Product ID
- 72189-512_2c4e6424-181c-1db8-e063-6294a90a52d9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rizatriptan Benzoate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA202490
- Marketing category
- ANDA
- Marketing start
- 2023-09-11
- Substance
- RIZATRIPTAN BENZOATE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rizatriptan Benzoate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIZATRIPTAN BENZOATE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | WR978S7QHH |
| Rxcui | 312840 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72189-512-18 | Rizatriptan Benzoate | 18 in 1 BOTTLE | TABLET | 18 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72189-512 | RIZATRIPTAN BENZOATE TABLET [DIRECT_RX] | 3 | Current NDC, 1 package rows | 20250123_05150193-cc2f-8b41-e063-6394a90a184c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72189-512-18 | 72189051218 | 18 TABLET in 1 BOTTLE (72189-512-18) | 18 tablet | 2023-09-11 | No | No | Current |